Rat sponge implant model: a new system for evaluating angiogenic gene transfer.

  • Authors:
    • H Wang
    • D Gordon
    • B Olszewski
    • Y L Song
    • I Kovesdi
    • J A Keiser
  • View Affiliations

  • Published online on: December 1, 2000     https://doi.org/10.3892/ijmm.6.6.645
  • Pages: 645-698
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Therapeutic angiogenesis, either by protein injection or gene therapy, holds considerable promise for the treatment of coronary and peripheral artery diseases. Given the large number of angiogenic genes available, a simple, well defined, standard system to compare the relative angiogenic efficacy of such genes would be valuable. We have employed a replication-deficient adenovirus vector (complete E1a-, partial E1b- and partial E3-) to deliver the beta-galactosidase (beta-gal, AdLacZ) reporter gene or the human VEGF121 gene (AdGV VEGF121.10) to a rat sponge implant model of angiogenesis. beta-gal staining results reveal a transfection efficiency as high as 60% 24 h after 2x1010 particle units AdLacZ injection. Our results also indicate that a single injection of 2x1010 particle units of AdGVVEGF121.10 in the sponge results in >10, 000 pg VEGF protein expression per milligram of sponge tissue 24 h later. VEGF121 protein concentrations decreased 10-fold within 3 days and 100-fold within 7 days after injection. Significant VEGF121 protein levels were still detectable 14 days after initial virus injection. The high level of gene transfection efficiency was accompanied by enhanced angiogenesis in the sponge, a tissue devoid of any vessels before implantation. Compared to control (AdNull: adenovirus vector without the VEGF gene), AdGVVEGF121.10 induced a 2- to 3-fold up-regulation of angiogenesis at 7 and 14 days post vector injection as determined by both increased capillary number and increased tissue ingrowth. The angiogenic effects of AdGVVEGF121. 10 were dose-related in this model system. These findings demonstrate a dose-related angiogenic response to adenovirus-mediated gene therapy in this model.

Related Articles

Journal Cover

Dec 2000
Volume 6 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang H, Gordon D, Olszewski B, Song Y, Kovesdi I and Keiser J: Rat sponge implant model: a new system for evaluating angiogenic gene transfer.. Int J Mol Med 6: 645-698, 2000
APA
Wang, H., Gordon, D., Olszewski, B., Song, Y., Kovesdi, I., & Keiser, J. (2000). Rat sponge implant model: a new system for evaluating angiogenic gene transfer.. International Journal of Molecular Medicine, 6, 645-698. https://doi.org/10.3892/ijmm.6.6.645
MLA
Wang, H., Gordon, D., Olszewski, B., Song, Y., Kovesdi, I., Keiser, J."Rat sponge implant model: a new system for evaluating angiogenic gene transfer.". International Journal of Molecular Medicine 6.6 (2000): 645-698.
Chicago
Wang, H., Gordon, D., Olszewski, B., Song, Y., Kovesdi, I., Keiser, J."Rat sponge implant model: a new system for evaluating angiogenic gene transfer.". International Journal of Molecular Medicine 6, no. 6 (2000): 645-698. https://doi.org/10.3892/ijmm.6.6.645